To predict the prognosis of HCC patients, a nomogram was developed based on the training cohort that integrated the PA-TACE timing with significant clinical characteristics, such as Ki-67, tumor size and MVI, for RFS (Figure 4A). The gene discussed is MKI67; the disease is neoplasm.